Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 687 of 1,261
  1. US 9375313

    Intramyocardial patterning for global cardiac resizing and reshaping

    The Regents of the University of California · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  2. US 2016175302

    MASITINIB FOR TREATING GASTRIC CANCER

    AB SCIENCE [FR] · Granted Jun 23, 2016 · Expires Jun 18, 2036

    granted
  3. WO 2016096933

    MASITINIB COMBINÉ À UTILISER DANS LE TRAITEMENT DU CANCER DU SEIN

    AB SCIENCE [FR] · Granted Jun 23, 2016 · Expires Jun 18, 2036

    granted
  4. CA 2968455

    COMPOSES ANTIBACTERIENS A LARGE SPECTRE D'ACTIVITE

    ACRAF [IT] · Granted Jun 23, 2016 · Expires Jun 18, 2036

    granted
  5. US 9370521

    Targeting GLI proteins in human cancer by small molecules

    The Regents of the University of California · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  6. US 9371352

    Modified glycolipids and methods of making and using the same

    VACCINEX, INC. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  7. US 9371337

    β-lactamase inhibitors

    The Regents of the University of California · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  8. US 9371316

    Pyridine derivatives

    Asana BioSciences, LLC · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  9. US 9370527

    Amelioration of intestinal fibrosis and treatment of Crohn's disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  10. US 9370519

    Macrocyclic FLT3 kinase inhibitors

    Oncodesign SA · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  11. US 9371287

    Process for making modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  12. US 9370582

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  13. US 9371277

    Benzamide compounds and related methods of use

    Northwestern University · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  14. US 9371320

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  15. US 9370559

    Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1

    The United States of America, as represented by the Secretary, Department of Heath Services · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  16. US 9370510

    Small molecule compounds to treat hearing loss

    Fate Therapeutics, Inc. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  17. US 9370525

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  18. US 9370514

    Methods for fine particle manufacture

    The Board of Regents of the University of Texas System · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  19. US 9372186

    Minimally-invasive measurement of esophageal inflammation

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  20. US 9371529

    RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions

    Arrowhead Research Corporation · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  21. US 9370505

    Pharmaceutical compositions comprising an aromatse inhibitors

    MEREO BIOPHARMA 2 LIMITED · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  22. US 9370487

    High oil-content emollient aerosol foam compositions

    Precision Dermatology, Inc. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  23. US 9371516

    Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells

    REGENERATIVE MEDICAL SOLUTIONS, INC. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted
  24. US 9371383

    Anti-ASIC1 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.